Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Yang, Hui Jun ^a   Kim, Young Eun ^b   Yun, Ji Young ^c   Kim, Han Joon ^b   Jeon, Beom Seok ^b  

^a Ulsan University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Mokdong Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL DREAMING; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLUSTER ANALYSIS; CONSTIPATION; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEMOGRAPHY; DISEASE DURATION; FEMALE; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; ONSET AGE; PARKINSON DISEASE; POSITIONAL DIZZINESS; URINARY TRACT DISEASE; VERY ELDERLY; EARLY DIAGNOSIS; MIDDLE AGED; ODOR; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SMELLING;

AGED; CLUSTER ANALYSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OLFACTORY PERCEPTION; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMELL;

EID: 84898603423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091906     Document Type: Article

References (36)

1. Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson's disease. J Neurol 249: 138-145. (Pubitemid 34143467)
2. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, et al. (2010) The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 25: 969-978.
3. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology 73: 206-212.
4. Graham JM, Sagar HJ (1999) A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 14: 10-20. (Pubitemid 29224671)
5. Gasparoli E, Delibori D, Polesello G, Santelli L, Ermani M, et al. (2002) Clinical predictors in Parkinson's disease. Neurol Sci 23 Suppl 2: S77-78. (Pubitemid 35355785)
6. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, et al. (2005) Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76: 343-348. (Pubitemid 40299121)
7. Schrag A, Quinn NP, Ben-Shlomo Y (2006) Heterogeneity of Parkinson's disease. J Neurol Neurosurg Psychiatry 77: 275-276.
8. Post B, Speelman JD, de Haan RJ (2008) Clinical heterogeneity in newly diagnosed Parkinson's disease. J Neurol 255: 716-722.
9. Reijnders JS, Ehrt U, Lousberg R, Aarsland D, Leentjens AF (2009) The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 15: 379-382.
10. Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, et al. (2004) Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol 251: 1383-1392.
11. van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, et al. (2011) Clinical subtypes of Parkinson's disease. Mov Disord 26: 51-58.
12. Perez Lloret S, Rossi M, Merello M, Rascol O, Cardinali DP (2011) Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study. Parkinsons Dis 2011:473579. doi:10.4061/2011/473579
13. van Rooden SM, Visser M, Verbaan D, Marinus J, van Hilten JJ (2009) Patterns of motor and non-motor features in Parkinson's disease. J Neurol Neurosurg Psychiatry. 80: 846-850.
14. Hong SC, Yoo YS, Kim ES, Kim SC, Park SH, et al. (1999) Development of KVSS test (Korean version of Sniffin' sticks test). Korean J Otolaryngol 42: 855-860.
15. Cho JH, Jeong YS, Lee YJ, Hong SC, Yoon JH, et al. (2009) The Korean version of the Sniffin' stick (KVSS) test and its validity in comparison with the cross-cultural smell identification test (CC-SIT). Auris Nasus Larynx 36: 280-286.
16. R ? ezanková H (2009) Cluster analysis and categorical data. Statistika 46: 216-232.
17. Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, et al. (2006) What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 129: 1640-1658. (Pubitemid 43999400)
18. Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, et al. (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease. Mov Disord 26: 621-628.
19. Suzuki R, Shimodaira H (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540-1542. (Pubitemid 43985330)
20. Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, et al. (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord 26: 2051-2057.
21. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, et al. (2009) Prevalence of smell loss in Parkinson's disease - a multicenter study. Parkinsonism Relat Disord 15: 490-494.
22. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, et al. (2005) Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128: 126-137. (Pubitemid 40070527)
23. Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, et al. (2011) Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 27: 617-626.
24. Morley JF, Duda JE (2011) Neuropsychological correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 310: 228-230.
25. Cramer CK, Friedman JH, Amick MM (2010) Olfaction and apathy in Parkinson's disease. Parkinsonism Relat Disord 16: 124-126
26. Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 310: 21-24.
27. Siderowf A, Lang AE (2012) Pre-motor Parkinson's disease: concepts and definitions. Mov Disord 27: 608-616.
28. Tolosa E, Gaig C, Santamar?́a J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72 Suppl 7: S12-20.
29. Chen H, Burton EA, Ross GW, Huang X, Savica R, et al. (2013) Research on the premotor symptoms of Parkinson's Disease: clinical and etiological implications. Environ Health Perspect 121: 1245-1252.
30. Liepelt-Scarfone I, Gauss K, Maetzler W, Mü ller K, Bormann C, et al. (2013) Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study. Neuroepidemiology 41: 174-182.
31. Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins K, et al. (2012) The PARS Investigators. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study. Mov Disord 27: 406-412.
32. Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, et al. (2013) The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 20: 102-108
33. Kim HJ, Park SY, Cho YJ, Hong KS, Cho JY, et al. (2009) Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 287: 200-204.
34. Lerner A, Bagic A (2008) Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23: 1076-1084.
35. Ravina B, Aarsland D (2013) Many roads lead to Parkinson's disease. Mov Disord 28: 122-123.
36. Goldstein DS, Sewell L, Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology 74: 245-251.